(Q57905710)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

title

An open-label trial in Friedreich ataxia suggests clinical benefit with high-dose resveratrol, without effect on frataxin levels (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Trevor A Mori

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Brigitte Sturm

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Adam P. Vogel

10

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Monique Ryan

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Paul J. Lockhart

19

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

21

Martin B Delatycki

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

author name string

Geneieve Tai

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Barbara Scheiber-Mojdehkar

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Monika Praschberger

9

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Gary Rance

11

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Creina Stockley

14

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Andrew Churchyard

16

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Eppie M Yiu

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Roger E Peverill

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Katherine J Lee

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Sarah E M Stephenson

12

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Joseph P Sarsero

13

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Chung-Yung J Lee

15

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Marguerite V Evans-Galea

17

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

Louise A Corben

20

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

publication date

7 April 2015

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

volume

262

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

issue

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

page(s)

1344-1353

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

https://scigraph.springernature.com/pub.10.1007/s00415-015-7719-2

4 March 2020

exact match

0 references

cites work

Clinical and genetic abnormalities in patients with Friedreich's ataxia

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Friedreich's ataxia: autosomal recessive disease caused by an intronic GAA triplet repeat expansion

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Frataxin is reduced in Friedreich ataxia patients and is associated with mitochondrial membranes

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Friedreich's ataxia: past, present and future

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Lateral-flow immunoassay for the frataxin protein in Friedreich's ataxia patients and carriers

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

What is new for an old molecule? Systematic review and recommendations on the use of resveratrol

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Review of recent data on the metabolism, biological effects, and toxicity of resveratrol in humans.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Pharmacological screening using an FXN-EGFP cellular genomic reporter assay for the therapy of Friedreich ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Measuring Friedreich ataxia: Interrater reliability of a neurologic rating scale.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Resveratrol modulates drug- and carcinogen-metabolizing enzymes in a healthy volunteer study

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Steady-State pharmacokinetics and tolerability of trans-resveratrol 2000 mg twice daily with food, quercetin and alcohol (ethanol) in healthy human subjects.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

A phase 2 study of SRT501 (resveratrol) with bortezomib for patients with relapsed and or refractory multiple myeloma

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

A high throughput electrochemiluminescence assay for the quantification of frataxin protein levels

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

FXN methylation predicts expression and clinical outcome in Friedreich ataxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Effects of low-fat or full-fat fermented and non-fermented dairy foods on selected cardiovascular biomarkers in overweight adults.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Urine 8-oxo-7,8-dihydro-2'-deoxyguanosine (8-oxodG), a specific marker of oxidative stress, using direct, isocratic LC-MS/MS: Method evaluation and application in study of biological variation in healthy adults

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Scale for the assessment and rating of ataxia: development of a new clinical scale

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Measuring Friedreich ataxia: complementary features of examination and performance measures

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Speech perception ability in individuals with Friedreich ataxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Reliability, stability, and sensitivity to change and impairment in acoustic measures of timing and frequency.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Friedreich's ataxia impact scale: a new measure striving to provide the flexibility required by today's studies.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Phase I dose escalation pharmacokinetic study in healthy volunteers of resveratrol, a potential cancer chemopreventive agent

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Correlation of frataxin content in blood and skeletal muscle endorses frataxin as a biomarker in Friedreich ataxia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

SIRT1 is required for AMPK activation and the beneficial effects of resveratrol on mitochondrial function

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Rating disease progression of Friedreich's ataxia by the International Cooperative Ataxia Rating Scale: analysis of a 603-patient database.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

How is disease progress in Friedreich's ataxia best measured? A study of four rating scales.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Measuring the rate of progression in Friedreich ataxia: implications for clinical trial design

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Evidence for a common mechanism of SIRT1 regulation by allosteric activators

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Mammalian sirtuins: biological insights and disease relevance

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Functional genomic analysis of frataxin deficiency reveals tissue-specific alterations and identifies the PPARgamma pathway as a therapeutic target in Friedreich's ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

PPAR-gamma agonist Azelaoyl PAF increases frataxin protein and mRNA expression: new implications for the Friedreich's ataxia therapy.

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

PGC-1alpha down-regulation affects the antioxidant response in Friedreich's ataxia

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Resveratrol pretreatment attenuates cerebral ischemic injury by upregulating expression of transcription factor Nrf2 and HO-1 in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Repeat dose study of the cancer chemopreventive agent resveratrol in healthy volunteers: safety, pharmacokinetics, and effect on the insulin-like growth factor axis

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

Phase I randomized, double-blind pilot study of micronized resveratrol (SRT501) in patients with hepatic metastases--safety, pharmacokinetics, and pharmacodynamics

21 January 2018

1 reference

https://api.crossref.org/works/10.1007%2FS00415-015-7719-2

International Cooperative Ataxia Rating Scale for pharmacological assessment of the cerebellar syndrome

21 January 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25845763

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Early changes in left ventricular long-axis function in Friedreich ataxia: relation with the FXN gene mutation and cardiac structural change

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/25845763

inferred from PubMed ID database lookup

12 December 2020

based on heuristic

Identifiers

DOI

10.1007/S00415-015-7719-2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:25845763%20AND%20SRC:MED&resulttype=core&format=json

4 March 2020

1 reference